What Is CME Fair Value?
CME Group Inc. (CME) fair value estimate using multiple valuation models, updated daily.
As of August 1, 2026, CME Group Inc. (CME) has a composite fair value estimate of $233.63 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $267.79, suggesting the stock is fair value by 12.8%.
Data as of August 1, 2026 (today)
Composite Fair Value
Fair Value4 of 4 models$233.63
vs. current price of $267.79(-12.8%)
How Is CME Fair Value Calculated?
Four independent models estimate what CME is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CME Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$319.60
+19.3%Undervalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$237.87
-11.2%Fair Value
Inputs used
CME Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$142.73
-46.7%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$122.67
-54.2%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $267.79 is 19.3% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $3.24B | $3.06B |
| Year 2 | $3.49B | $3.11B |
| Year 3 | $3.75B | $3.15B |
| Year 4 | $4.03B | $3.20B |
| Year 5 | $4.33B | $3.24B |
| Year 6 | $4.65B | $3.29B |
| Year 7 | $5.00B | $3.34B |
| Year 8 | $5.38B | $3.39B |
| Year 9 | $5.78B | $3.44B |
| Year 10 | $6.22B | $3.49B |
| Terminal Value | $185.30B | $104.08B |
What Are CME's Key Financial Metrics?
Earnings & Growth
Current Price
$267.79
EPS (TTM)
$11.78
Forward P/E
20.7
Profit Margin
63.4%
Cash & Balance Sheet
Free Cash Flow
2.9B
EBITDA
4.8B
Book Value
$73.82
Total Debt
3.9B
What Do Analysts Say About CME?
Low
$230.00
Average
$283.93
High
$330.00
Upside
+6.0%
CME Fair Value FAQ
What is the fair value of CME?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CME's estimated fair value is $233.63. The stock is currently trading at $267.79, which makes it fair value by our analysis.
How is CME's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CME overvalued or undervalued?
Based on our analysis, CME is fair value. The current price of $267.79 is 12.8% above our estimated fair value of $233.63.
What do Wall Street analysts say about CME?
15 analysts cover CME Group Inc. with a consensus rating of "Buy." The average price target is $283.93, ranging from $230.00 to $330.00. This implies 6.0% upside from the current price.